chrisvoncsefalvay/vaers-outcomes huggingface dataset:
vomiting; loss of appetite; dizziness; arm hurt; arm swollen a little bit; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (loss of appetite), DIZZINESS (dizziness), PAIN IN EXTREMITY (arm hurt), PERIPHERAL SWELLING (arm swollen a little bit) and VOMITING (vomiting) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included VITAMIN B12 NOS, ASCORBIC ACID (VITAMIN C ACID) and CALCIUM.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm hurt) and PERIPHERAL SWELLING (arm swollen a little bit). On 12-Jan-2021, the patient experienced DECREASED APPETITE (loss of appetite) and DIZZINESS (dizziness). On an unknown date, the patient experienced VOMITING (vomiting). At the time of the report, DECREASED APPETITE (loss of appetite), DIZZINESS (dizziness), PAIN IN EXTREMITY (arm hurt), PERIPHERAL SWELLING (arm swollen a little bit) and VOMITING (vomiting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.    No treatment information was provided   Most recent FOLLOW-UP information incorporated above includes: On 20-Jan-2021: No specific follow-up information recorded.
Thrombocytopenia; Blood blisters; This is a spontaneous report from a Pfizer-sponsored program COVAX Support. A contactable Other-HCP reported for a 81-year-old female patient that received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Deltoid Left on 19Apr2021 (Lot Number: ER8737; Expiration Date: Jul2021) as 1ST DOSE, SINGLE for covid-19 immunisation  .  Medical history included deep vein thrombosis. Concomitant medication included apixaban (ELIQUIS) taken for deep vein thrombosis from 29Apr2021 to 30Apr2021.  The patient experienced thrombocytopenia and blood blisters on 29Apr2021.  The patient was hospitalized for thrombocytopenia from 29Apr2021 to 02May2021.  The patient visited emergency room and physician office due to thrombocytopenia. The patient underwent lab tests and procedures which included platelet count: 3,000/dropped on 29Apr2021, platelet count: 348,000 on 04May2021.  Therapeutic measures were taken as a result of thrombocytopenia included platelets. The outcome of events was recovered.; Sender's Comments: As there is limited information in the case provided, the causal association between the event thrombocytopenia and the suspect drug BNT162B2 cannot be excluded. The case will be reassessed once new information is available.
Patient became dizzy and syncopal and laid on table for 5 min. Blood pressure 100/50. Drank H2O. Walked out of office with mom 5 min later completely recovered.
A report received from a health professional on 08Nov02, concerning a female vaccinee  who inadvertently received Fluvirin SC on 07Nov02. On 07Nov02 the vaccinee received 0.5ml Fluvirin SC.  No adverse event was reported in relation to the incident. There was insufficient information to determine the reporter's causality assessment.  Cross reference with: PJP200200731, PJP200200729, PJP200200743, PJP200200728, PJP200200742, PJP200200741, PJP200200720, PJP200200745.
p/vax pt c/o rt arm redness & impetiginivation 8mm x 10mm;
Patient had filled out questionnaire stating he had not received a covid vaccine.  Pt received Jansen vaccine on 3/29 but after inputting his inoformation , we noticed he had already received the first dose of Moderna previously.  We followed up and patient states felt no side effects or adverse events. He then stated he had previously received Moderna.
Shortly after receiving his first dose of the covid vaccine, Pt was in the observation area and felt he was going to pass out and signaled for help.  He had reported a cold sweat, was clammy, and stomach ache.  His pupils were uneven, right larger than left. His respirations were stable.  He stated that he had not eaten much and doesn't do well with needles in general. Cold pack was applied and vitals monitored. Vitals 1434 BP 84/42, P 57, O sat 95 1439 BP 102/67 P 64, O sat 95 1444 BP 117/80 P 78  O sat 94 1458 BP 108/76 P 76 1505 BP 114/74 P 75  O sat 96 Suggested to patient to talk to PCP about 2nd dose, pt stated he will not return for 2nd dose At time of dismissal patient felt he had fully recovered
Body felt normal with a little stiffness in neck.  Felt tired and went to bed but in bed started experiencing chills. I put a heating pad on the bed and even though the bed and pad felt warm, the chills continued for about 10 minutes. Later in the night, my daughter came and checked my temperature. It was 105, even though I didn't feel like I had any fever. I took some Ibuprofen and my daughter put a cool damp cloth on my forehead. I never felt hot. In the morning, the area in the bed where I was sleeping was completely soaked!  My temperature was normal.
This case was reported by a nurse via sales rep and described the occurrence of extensive swelling of vaccinated limb in a female patient who received SHINGRIX. In March 2018, the patient received SHINGRIX. In March 2018, less than a week after receiving SHINGRIX, the patient experienced extensive swelling of vaccinated limn and injection site erythema. On an unknown date, the outcome of the extensive swelling of vaccinated limb was recovering/resolving and the outcome of the injection site erythema was unknown. It was unknown if the reporter considered the extensive swelling of vaccinated limb and injection site erythema to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not provided. The patient received SHINGRIX 5 to 6 days ago and experienced some extreme swelling from shoulder to hand, and some excess redness at the injection site. It was reported that 5 to 6 days later, there was still some swelling, but not that much.
Per clinic note, on 7/9/12, patient noticed painful, itchy rash 2 weeks ago.
This spontaneous report was received from a health care professional refers to unknown number of patients of unknown demographics. On an unknown date the patients were vaccinated with GARDASIL injection lot # K006960; expiry: 19-FEB-2017 (dose, route and frequency unspecified). On an unknown date, the patients were administered GARDASIL 9 that had been improperly stored. No adverse effects reported. No further information provided. The outcome of incorrect product storage and no adverse event is unknown. No product quality complaint involved. Additional information has been requested.
Arm pain at injection site; This is a spontaneous report received from a contactable pharmacist. A 43-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EK5730), Solution for injection, intramuscular, administered in Arm Right on 21Dec2020 (at the age of 43-year-old) as single dose for covid-19 immunisation. The patient medical history including any illness at time of vaccination was reported as none. Concomitant medications included ergocalciferol (VIT D [ERGOCALCIFEROL]) at 1000 units PO (oral) daily taken for supplementation therapy, docusate sodium (COLACE) at 100 mg PO (oral) daily taken as stool softener, loratadine (CLARITIN [LORATADINE]) at 10 mg PO (oral) daily PRN (as needed) taken for seasonal allergy, fluticasone propionate (FLONASE [FLUTICASONE PROPIONATE]) at 50 mcg/ spray + spray daily PRN (as needed) each nostril taken for seasonal allergy. On 21Dec2021, the patient experienced arm pain at injection site. Patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EK9231), Solution for injection, intramuscular, administered in Arm Right on 11Jan2021 at 13:00 as 0.3 ml, single dose for covid-19 immunisation. The outcome of event was unknown.   Follow-up attempts completed. No further information expected.
Fever of 102.6 Body felt cold. lasted 4 hrs. Tx: tylenol, sleep
Rash and small white dots on both palms. Left palm is worse than left palm. Feel itchy and dull pain if touched. Swelling in both palms.
Within first 5 minutes, pt reports feeling dizzy and lightheaded and that throat was tight and it was difficult to swallow. Symptoms did not progress. Benadryl was considered but with medical staff, agreed to observe for worsening over the subsequent 5 minutes. Symptoms slowly resolved and by 12:10 throat just feeling dry. No dizziness reported.
The first night after being vaccinated, I began having a really bad headache, swelling at the injection site, and joint pain. The next day, I experienced severe muscle weakness, and it progressed to the point that I could not walk, stand, or go to the bathroom on my own. My back had shooting pains into my legs, my joints were severely sore, and I could not lift my legs from the floor. My stomach ached and I was constipated. When I visited immediate care at the hospital, I had not muscle reflex and had to be escorted in a wheel chair.
I WAS TAKEN BY AMBULANCE TO HOSPITAL WITH AFIB ON 02/10/2021
Pain starts at forearm and goes up to where the shot was given. No pain is in the shoulder. Any pressure that is applied, he has a strong pain that. He can feel where the shot was given,
Initial itching and muscle ache - then by the next morning noticed a hive approximately 5" x 3". The area is very warm to the touch, swollen, pink and sore.  Also a very slight headache.
Fever that lasted 60 hours and fluctuated between 99.3-101.5 while taking Tylenol. Body aches, headache, pain at injection site
Temp of 100.3 and mild swelling of left thigh.  Parent reports that Patient had no reaction to 1st dose but had a mild reaction to 2nd dose and now.
No adverse reaction to vaccine #4 taken on 3/29/2022. Contracted COVID-19 80 days later.
Swollen lymph node under left arm. Left arm is where vaccine was given. Swelling is about the size of a tennis ball.
Red , raised lesions on right thigh.  Initially 9 spots, increasing over 4 days to total of  21 raised spots about the diameter of a pencil eraser, larger, flat redness around each lesion.  At about 5 days, tiny heads began to form.  Day 8, redness began to fade. After 2 1/2 weeks,  tiny scabs cover the center of each lesion and only purple  discoloration remains at each site.  The 21 spots were spread over inner thigh, front of thigh and outer thigh.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE ACUTE HYPOXEMIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY
Itchy back near left shoulder blade, swelling of throat, tongue, and lips, stuffy nose, racing heartbeat, and feeling of impending doom.
HA Arm sore chills body aches dizzy (lighthead) Nasuea.
Fully body hives and a rash developed 10 days after. Still ongoing over 20 days later. I've been on 80mg Prednisone for 3 days, 60mg for 3 days, 40mg for 3 days and 20mg for 2 days. I also have take Zyrtec or Claritin. I was also given 2 shots of dexamethasone. One on the 2nd day of my hives, the other shot was almost 3 weeks in. I've tried Benadryl and topical creams as well.
rash on all four extremities and trunk/he has a pruritic rash covering all 4 of his extremities and most of his trunk/scratchy/itchy sensation in the throat, rash and pruritus.; rash on all four extremities and trunk/he has a pruritic rash covering all 4 of his extremities and most of his trunk/scratchy/itchy sensation in the throat, rash and pruritus.; rash on all four extremities and trunk/he has a pruritic rash covering all 4 of his extremities and most of his trunk/scratchy/itchy sensation in the throat, rash and pruritus.; This is a spontaneous report from a contactable physician (patient). An 81-years-old male patient received second dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, Batch/Lot Number: EN5318), via an unspecified route of administration on 02Feb2021((at the age of 81-years-old) as single dose for COVID-19 immunization. The patient's medical history had diabetes. He was diagnosed his first year in medical school in 1968. Concomitant medications were not reported. The patient received first dose of bnt162b2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, Batch/Lot Number: EL3246) on 12Jan2021 as historical vaccination as single dose for covid-19 immunization. On 03Feb2021 patient experienced rash on all four extremities and trunk/he has a pruritic rash covering all 4 of his extremities and most of his trunk/scratchy/itchy sensation in the throat, rash and pruritus. Clinical course of events: within 24 hours, after the patient had the second shot patient had no symptoms until late next day, then rash on all four extremities and trunk/ had a pruritic rash covering all 4 of his extremities and most of his trunk. It was not on his face. Then atter night, it got much worse next day. He states that he has taken a Benadryl and Pepcid which was helped with the itching but the rash has not gone away. The outcome of the events was not recovered.  Follow-up attempts are completed. No further information is expected.
HD received report of a vaccine recipient experiencing significant side effects after receiving Janssen vaccine. Health department spoke with patient on 4/9/2021 at 11:20AM. Patient reported generalized body aches starting on 3/22/2021 at 11:00PM. On 3/23/2021 at 12:00AM patient reported emesis that resolved after 30 minutes, chills, and a fever. Tmax, measured orally by patient, was 106F on 3/23/2021 at 2:00AM. Patient's wife called the Emergency Department, who advised patient to take tylenol and advil and to come into emergency department if temperature did not start coming down. Oral temperature by 3AM was 104F and was 100F by 8AM on 3/23/2021. Patient reported that all side effects resolved by 3/24/2021.
pain is still felt on the right arm from the first dose; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain is still felt on the right arm from the first dose) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain is still felt on the right arm from the first dose). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (pain is still felt on the right arm from the first dose) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Additional concomitant medication includes allergy pills which the patient takes everyday. No further information was provided.   This case was linked to MOD-2021-043052 (Patient Link).
patient was shaky and laid on the floor for 20 minutes after with feet elevated. patient had no further issues.
Patient called on 6/8 to report symptoms in left upper arm of soreness, redness, swelling, warm to touch. Patient said redness had began to spread downward from the injection site.  Patient called her PCP on 6/8 and was directed to take benadryl and call PCP back if got worse. When I spoke to patient, I told her that putting ice on the area might help. She said she would do that and call me back on 6/9 if got worse. I spoke with patient on 6/9 at 1025am. She said that the swelling had gone down and that she was going to take more benadryl today and follow up with her PCP if symptoms got worse.
Developed rash around  front neck area and below neck , sensitivity to touch. Lasted about 10 days  with still some sensitivity today. Four days after the injection I had pain in lower jaw that at fist I though was a tooth ache. It was on the same side of my body as the shoot ( left side) . Lasted several days and on the sixth day  after the shoot also hurt on the other side of my mouth(lower back teeth area) but milder  and gone the next day.  Spoke with my Doctor, she recommends the second shoot since my reactions were not severe.
Patient received FLu Mist on 25Aug09. Before administering vaccine patient submitted a negative pregnancy test. 28Aug09 patient took a second test and it was positive.
Right upper arm red and swollen. Treatment: Cool compresses, BENADRYL every 6 hours and MOTRIN. Seek medical attention for facial swelling or hard or fast breathing.
This spontaneous report was received from a physician regarding unspecified number of patients of unknown age. There was information about concurrent condition and historical medication. On an unknown date, the patients were vaccinated with unspecified doses of improperly stored VAQTA lot # K019560, Expiration Date- 02-JUN-2017, (dose strength and route was unknown). No concomitant medication was reported. No adverse event reported. No product quality complaint was involved. The outcome of the event was unknown. This is one of the several reports from the same reporter. Additional information has been requested.
cough; headache; chill; heaving period than usual (2 weeks); 2nd day developed sore throat and slight fever; 2nd day developed sore throat and slight fever; Sore arm within of few hours of getting the 1st and 2nd dose of Pfizer-BioNTech COVID-19 Vaccine This is a spontaneous report from a contactable consumer reported for herself that. A 33-years-old female patient received BNT162B2 (Pfizer-BioNTech COVID-19 Vaccine solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 02Sep2021 16:00 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunization (Age at vaccination 33 years). The patient medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within 4 weeks prior to covid-19 vaccination. There were no allergies was reported. The patient has not received other medications in two weeks. The patient experienced Sore arm within of few hours of getting the 1st and 2nd dose of Pfizer BioNTech COVID-19 Vaccine EUA on 02Sep2021 2nd day developed sore throat and slight fever on 03Sep2021. On 4Sep2021, Day 3-9 fever, cough, headache chill, heaving period than usual (2 weeks), sore throat, and fever like symptoms. The AE resulted in: Doctor or other healthcare professional office/clinic visit. No treatment was received. The event outcome was recovering.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
PT WAS GIVEN MMRV/PROQUAD AT 13 YEARS OLD AND IT IS LICENSED FOR AGE UP 12 YEARS OLD
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; This spontaneous report received from other company (Pfizer) via a patient concerned a 55-year-old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: asthma, and sulfa allergy. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin not reported, batch number: 026D21 A expiry: UNKNOWN) dose was not reported, administered 1 in total on 24-MAR-2021 for covid-19 prophylaxis. Age at time of vaccination 54 years old. On 23-SEP-2022, the patient experienced confirmed clinical vaccination failure following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series 1). Patient received non-company suspect vaccine included: elasomeran (Moderna vaccine) (Dose number in series 2) (batch number: 056M21A expiry: UNKNOWN, form of admin, route of admin, and were not reported) dose was not reported, administered on 24-OCT-2021 for covid-19 prophylaxis.  On 24-OCT-2021, the patient experienced revaccination with different covid-19 vaccine following vaccination with elasomeran (Dose number in series 2). Patient received non-company suspect vaccine included: elasomeran (Moderna vaccine) (Dose number in series 3) (batch number: 056MZ1 A expiry: UNKNOWN, form of admin, route of admin, and were not reported) dose was not reported, administered on 13-MAY-2022 for covid-19 prophylaxis. No concomitant medications were reported.  On 23-SEP-2022, the patient experienced confirmed covid-19 infection. Laboratory data included: COVID-19 virus test Positive following vaccination with elasomeran (Dose number in series 3).  Patient received non-company drug included: paxlovid (batch number: Unknown expiry: Unknown, form of admin, route of admin, and were not reported) dose was not reported, administered from 23-SEP-2022 to 27-SEP-2022 for covid-19 treatment. On 28-SEP-2022, Laboratory data included: COVID-19 virus test Positive. On 01-OCT-2022, Laboratory data included: COVID-19 virus test Negative, patient started feeling better and then again started feeling sick. On 04-OCT-2022, Laboratory data included: COVID-19 virus test Positive. The action taken with covid-19 vaccine ad26.cov2.s, elasomeran, and elasomeran was not applicable. The patient was recovering from confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure and revaccination with different covid-19 vaccine was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint, and reference number requested. Sender's Comments: V0:20221027458-covid-19 vaccine ad26.cov2.s- Confirmed Clinical Vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Fever of 101- 102, headache, body aches, chills. Resolved in 12 hours. Woke up in the morning next day with headache and minor body aches
Boerhaave syndrome. ED visit to hospital admission. This visit was within 6 weeks of receiving the COVID vaccine.
We are useing the Drive thru method at Airport. Client recieved COViD 19 vaccine and after getting it drove to  Recovery Room. Client stated in Recovery Room she felt a little N/. She wanted to stand uo, so she did and then drank some water. She felt better and we made her sit in the 30 minute line. After the 30 min, were over, she felt better and went home. Told her if she had any othr problems to call her Dr.
Micah began having seizures 11 days after vaccination.  There have been no other health problems whatsoever in Micah.  He has had an occasional ear infection but very healthy since birth.  He continued to have seizures and we were referred to pediatric neurologist.  EEG and MRI were done.  No abnormalities were found.  Seizures continued and Micah had to be put on Lamectil - He is taking 50mg daily.  It has slowed down seizure activity to near missed, occasional seizures.  The Lamectil required cost $1000 a month - 50mg - dose cost $200 a month.
SORE THROAT, COUGH, FEVER, NAUSEA, BODY ACHES, TACHYCARDIA
Peeling skin like sunburn.  Dry and peeling in large area around injection site.
[Product Covid vaccine-Pfizer name] use for COVID-19 under Emergency Use Authorization (EUA):after 1st dose of Pfizer Covid vaccine, arm chills, tingling, chill bumps 4 times a day for 3 weeks.
Flat red sl tender rash at injection site appeared 2 days after inj. and enlarged to 3x5 cm. Now fading. Pain (L) shoulder region developed 2 days post-injection and worsened w/limited ROM. Vaccine administered on 2/23/16.